ARMP vs AAPL: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

AAPL has stronger fundamentals based on our AI analysis.

ARMP
Armata Pharmaceuticals, Inc.
D
96%
Confidence
VS
AAPL
Apple Inc.
A
87%
Confidence

ARMP vs AAPL Fundamental Comparison

Metric ARMP AAPL
Revenue $31,000.0 $254.9B
Net Income $-115.3M $71.7B
Net Margin -372,083.9% 28.1%
ROE N/A 67.3%
ROA -165.3% 19.3%
Current Ratio 0.64x 1.07x
Debt/Equity N/A 0.78x
EPS $-3.16 $4.85

Green = Better metric | Red = Weaker metric

View Full ARMP Analysis →
View Full AAPL Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Top Rated Undervalued Growth Dividend

You Might Also Compare

ARMP vs MSFT AAPL vs GOOGL ARMP vs AMZN AAPL vs NVDA

ARMP vs AAPL: Frequently Asked Questions

Is ARMP or AAPL the better stock in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. ARMP is graded D (96% confidence) while AAPL is graded A (87% confidence). This is not investment advice.

How does ARMP compare to AAPL fundamentally?

Armata Pharmaceuticals, Inc. has ROE of N/A vs Apple Inc.'s 67.3%. Net margins are -372,083.9% vs 28.1% respectively.

Which stock pays higher dividends, ARMP or AAPL?

ARMP has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ARMP or AAPL for long term?

For long-term investing, consider that ARMP has a D grade with 96% confidence, while AAPL has a A grade with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ARMP vs AAPL?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ARMP vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.